Although the business process of “Out-Licensing” is broadly agreed and understood, the way in which different companies go about implementing the process is widely varied. This variation depends to some extent on the size of the company, available resources, the type of product or drug being offered, the product’s development and research stage and of course the internal processes of the company.
What this whitepaper shows is how you might implement your own Out-Licensing process by comparing two cases with different approaches using the same Brainloop solution. Because Brainloop’s customers can expect not only the absolute confidentiality of their documents, but the confidentiality of their processes, these different experiences are not exactly those of our customers.
Out-Licensing and Beyond - Secure Document based processes for the Life Sciences Industry
Pharmaceuticals & Biotechnology Editor | 09/26/2012